Clinical Trials

  • Principal Investigator

    Carolyn L. Westhoff, MD
    The UPA Breast Study will investigate a medication called ulipristal acetate (UPA), which is currently used as an emergency contraceptive and as a treatment for fibroids. The study is designed to investigate 1) whether taking UPA daily can decrease breast cell proliferation compared to traditional combined oral contraceptive pills; and 2) whether MRI can replace biopsies in future research studies investigating breast proliferation, as substituting biopsies for MRI would make future studies easier for women to take part in. Study participation will last 4-5 months.
  • Principal Investigator

    Ana I. Tergas, MD
    This research study is designed to see if olaparib is effective in treating high-grade epithelial ovarian,fallopian tube, or primary peritoneal cancer and whether it causes any side effects.A capsule formulation of olaparib (tradename Lynparza) is approved by the European Commission(EC), US Food and Drug Administration (FDA) and other countries for the treatment of advanced BRCA-mutated ovarian cancer in women.A tablet formulation of olaparib is being tested in this study.